Vivus Arousal Disorder Drug Fails Study - Houston Chronicle
Saturday, September 30th, 2006Vivus Arousal Disorder Drug Fails StudyHouston Chronicle, United States - 10 hours ago… the company will shift its focus to its obesity treatment candidate Qnexa and its Testosterone MDTS for the treatment of hypoactive sexual desire disorder. … VIVUS Announces Results of ALISTA Phase 2b Study Yahoo! News (press release)all 9 news articles
Read full story